PERSISTENCE POSITIVITY OF LACTATE DEHYDROGENASE RAPID DIAGNOSTIC TESTS ANTIGENS IN PREGNANT WOMEN AFTER ANTIMALARIA TREATMENT IN SOME HOSPITALS IN KATSINA
Abstract
Malaria is a life-threatening disease caused by parasites transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. This study investigates the persistent positivity of Lactate Dehydrogenase (pLDH) Rapid diagnostic tests antigens in pregnant women after antimalarial treatment. The study was conducted in Turai Yaradua Maternity and Children’s Hospital Katsina and Federal Medical Centre Katsina. Samples were collected with the help of trained physicians. The result from this study shows that lactate dehydrogenase antigen persists in the blood after treatment with fensider (antimalaria drug). After administering the drug to the pregnant women found to be positive for malaria, it was observed that in all the age groups, day 3, day 7, and day 14 post-drug treatment were all still positive for malaria using the pLDH malaria rapid diagnostic tool. It was also observed that after 21 days post-treatment, all the different age groups were still positive for malaria except those aged 45 to 50 (95.0%). There is no statistically significant difference between the age of pregnancy p>0.05. The percentage positivity of pLDH started changing day 21 in 3rd trimester and the change peak at day 28 post-drug treatment in all three trimesters. There is no statistical significance difference between the age of pregnancy p>0.05. However, the first trimester shows the highest negative result (66.7%). It also shows that age, tribe, trimester of pregnancy, and occupation were statistically not associated with the persistence positivity of the pLDH. The parasite density might be responsible..
References
Abeku, T. A., Kristan, M., Jones, C., Beard, J., Mueller, D. H., Okia, M., Rapuoda, B., Greenwood, B. and Cox, J. (2008). Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission setting in the East African highlands. Malaria Journal. 7: 202. DOI: https://doi.org/10.1186/1475-2875-7-202
Alemayehu, G.S., Blackburn, K., Lopez, K., Dieng, C.C., Lo, E., James, D. and Golassa, L. (2021). Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Assosa zone, Ethiopia: Implication for malaria diagnosis. Malaria Journal. 20: 109. DOI: https://doi.org/10.1186/s12936-021-03629-x
Amoah, L. E., Abankwa, J., and Oppong, A. (2016). Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Malaria journal. 15(1): 1-8. DOI: https://doi.org/10.1186/s12936-016-1159-z
Ayona, S.B., Shrier, S.L, Gichuki, C.W., Waitumbi, J.N., Githerko, A., Brandling-Bannett, A. (2006). Pitting of malaria parasites and spherocyte formation. Malaria Journal. 5: 64. DOI: https://doi.org/10.1186/1475-2875-5-64
Ellen, S. (2024) "Slovin's Formula Sampling Techniques" sciencing.com, https://sciencing.com/slovins-formula-sampling-techniques-5475547.html. Accessed May 2024
Falade, C. O. (2016). Malaria rapid diagnostic tests and malaria microscopy for guiding malaria treatment of uncomplicated fevers in Nigeria and pre-referral cases in 3 African countries. Clinical. Infectious. Disease. 63: 290–297 DOI: https://doi.org/10.1093/cid/ciw628
Houmsou, R. S., Amuta, E. U., Sar, T. T. and Adagba, A. H. (2011). Malaria infection among patients attending a Nigerian semi-urban based hospital and performance of HRP-2 pf Rapid diagnostic Test (RDT) in screening clinical cases of plasmodium falciparum malaria. Translational Biomedicine. 2 (1): 2172
Hopkins, H., Kambale, W., Kamya, M. R., Staedke, S. G., Dorsey, G. and Rosenthal, P.J. (2007). Comparison of HRP2 and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. The American Society of Tropical Medicine and Hygiene. 76(6): 1092-1097. DOI: https://doi.org/10.4269/ajtmh.2007.76.1092
Helsinki (2008). Declaration of Helsinki ethical principles for Medical Research Involving Human Subjects. The World Medical Association, INC. Seoul, Korea https://www.wma.net.
Iqbal, J., Siddique, A., Jameel, M. and Hira, P.R. (2004). Persistent histidine-rich protein 2, parasite lactate dehydrogenase and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. Journal of Clinical Microbiology. 42: 4237-4241. DOI: https://doi.org/10.1128/JCM.42.9.4237-4241.2004
Kattenburg, J. H., Taluta, C. M., Verteeg, I. A. J., Tinto, H., Traore-Coulibaly, M., Schallig, H. D. F. H. and Mens, P. F. (2012). Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy. Tropical Medicine and International Health. 17(5): 550-557. DOI: https://doi.org/10.1111/j.1365-3156.2012.02975.x
Kozycki, C. T., Umulisa, N., Rulisa, S., Mwikarago, E. I., Musabyimana, J. P., Habimana, J. P. and Krogstad, D. J. (2017). False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malaria journal.16:1-11. DOI: https://doi.org/10.1186/s12936-017-1768-1
Laurent, A., Schellenberg, J., Shirima, K., Ketende, S.C., Alonso, P.I., Mshinda, H., Tanner, M., Schellenberh, D. (2010). Performance of HRP-2 based rapid diagnostic test for malaria and its variation with age in an area of intense malaria transmission in Southern Tanzania. Malaria Journal; 9: 294. DOI: https://doi.org/10.1186/1475-2875-9-294
Ly, A. B., Tall, A., Perry, R., Baril, L., Badiane, A., Faye, J., Rogier, C., Toure, A., Sokhna, C., Trape, J. F. and Michel, R. (2010). Use of HRP2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malaria Journal. 9: 153. DOI: https://doi.org/10.1186/1475-2875-9-153
Mayxay, M., Pukrittayakamee, S., Chotivanich, K., Lwareesuwan, S. and White, N.J. (2001). Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene; 95: 179-182. DOI: https://doi.org/10.1016/S0035-9203(01)90156-7
Michael, O. S., Orimadegun, A. E. and Falade, C.O. (2021). Persistence of Plasmodium falciparum HRP2 Antigen After Effective Antimalarial Therapy. Annals of Ibadan Postgraduate Medicine. 19(1): 15-21.
Moody, A. (2002). Rapid diagnostic tests for malaria parasites. Clinical Microbiology Review; 15: 66-78. DOI: https://doi.org/10.1128/CMR.15.1.66-78.2002
Ndour, P. A., Larreche, S., Mouri, O., Argy, N., Gay, F., Roussel, C. (2017). Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis. Translational Medicine. 9: 9377. DOI: https://doi.org/10.1126/scitranslmed.aaf9377
Oladosu, O. O., Adedokun, V. A., Adeniyi, A. V. and Oyibo, W.A. (2021). Performance Evaluation of Malaria HRP2 Rapid Diagnostic Test among Febrile Patients with Malaria in Iwo, Osun State, Nigeria. International Journal of Tropical Diseases. 4: 046. DOI: https://doi.org/10.23937/2643-461X/1710046
Poti, K. E., Balaban, A. E., Pal, P., Kobayashi, T., Goldberg, D. E., Sinnis, P. and Sullivan, D.J. (2019). In vivo compartmental kinetics of Plasmodium falciparum histidine-rich protein II in the blood of humans and in BALB/c mice infected with a transgenic Plasmodium berghei parasite expressing histidine-rich protein II. Malaria Journal. 18, 78. DOI: https://doi.org/10.1186/s12936-019-2712-3
Swarthout, T. D., Counihan, H., Sanga, P.K., Broek, I. (2007). Paracheck-pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malaria Journal. 6: 58. DOI: https://doi.org/10.1186/1475-2875-6-58
Tidi, S. K. and Akogun, O. B. (2005). Effectiveness of rapid test technique (RTT) in malaria diagnosis and chloroquine treatment failures in Yola, Nigeria. Nigerian Journal of Parasitology. 26: 49-54. DOI: https://doi.org/10.4314/njpar.v26i1.37729
World Health Organization. (2020). World malaria report 2019. Geneva: World Health Organization; 2019. Fecha de consulta.
World Health Organisation (2011). Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva: World Health Organization;
Copyright (c) 2024 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
